Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2026-01-12 @ 5:42 AM
Study NCT ID:
NCT02900716
Status:
COMPLETED
Last Update Posted:
2020-11-27
First Post:
2016-08-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas
Sponsor:
Zhejiang DTRM Biopharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09
Start Date Type:
None
Primary Completion Date:
2020-11-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-18
First Submit QC Date:
None
Study First Post Date:
2016-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-24
Last Update Post Date:
2020-11-27
Last Update Post Date Type:
ACTUAL